摘要 : Tyrosine kinase inhibitors are a class of targeted anticancer drugs that inhibit cancer cell proliferation by inactivating proteins involved in signal transduction cascades. Various cutaneous adverse events have been observed afte... 展开
作者 | Jason J.Yang Nolan J. Maloney Kevin A. Nguyen Scott Worswick Jan Smogorzewski Daniel Q. Bach |
---|---|
作者单位 | |
期刊名称 | 《Dermatologic therapy.》 |
总页数 | 1 |
语种/中图分类号 | 英语 / R75 |
关键词 | adverse effects of oncologic drugs drug-induced sweet syndrome neutrophilic dermatosis sweet syndrome targeted anticancer therapy tyrosine kinase inhibitor |
馆藏号 | N2008EPST0013735 |